Clinical Trials
4 trialsNCT05576896 2026-06-04
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
Northwestern University
Phase 2 Active not recruiting
NCT04523857 2026-05-26
ABBY
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting
NCT05518110 2026-04-13
PaTcH
Cancer Trials Ireland
Phase 2 Terminated
NCT04841148 2026-04-09
PALAVY
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting